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Abstract 
Purpose: To determine the cross-sectional and cumulative compliance of adolescent girls to 
accelerometer wear at three deployment points and to identify variables associated with 
compliance. Methods: Girls from 20 secondary schools were recruited: 10 schools were 
participating in the ‘Girls Active’ intervention and 10 were control schools. Physical activity was 
measured using the GENEActiv accelerometer worn on the non-dominant wrist 24 hours/day for 
up to 7-days at baseline, 7-months and 14-months. Demographic and anthropometric 
characteristics were recorded. Results: Seven valid days (>16 hours) of accelerometer wear were 
obtained from 83%, 77% and 68% of girls at baseline (n = 1734), 7-months (n = 1381) and 14-
months (n = 1326), respectively. 68% provided 7-valid days for both baseline and 7-months, 59% 
for baseline and 14-months and 52% for all three deployment points. Estimates of physical activity 
level from 3-days of measurement could be considered equivalent to a 7-day measure (i.e. they 
fell within a ±5% equivalence zone). Cross-sectionally, 3-valid days were obtained from at least 
91% of girls; cumulatively, this was obtained from >88% of girls across any two deployment points 
and 84% of girls across all three deployment points. When controlling for clustering at school level 
and other potential predictors, physical activity level, being South Asian, being in the intervention 
group and prior compliance were positively associated with monitor wear. Conclusion: 
Compliance reduced across deployment points, with the reduction increasing as the deployment 
points got further apart. High prior compliance and high physical activity level were associated 
with the most additional wear-time. 
 
Key words: physical activity; GENEActiv; Girls Active; longitudinal; intervention; predictors of 
compliance; 24 h wear 
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Introduction 
 
Accurate and objective measurement of physical behaviours (physical activity, sedentary time and 
sleep) is important for population surveillance, intervention studies aiming to change behaviours 
and cohort studies. Furthermore, as sleep, sedentary behaviour and physical activity are linked to 
the vast majority of chronic diseases and other health outcomes (1), they are potential 
confounders in any research project analysing associations between exposures and health, thus 
require accurate measurement. Increasingly, wearable accelerometers are used to obtain an 
objective measure of people’s physical activity. Until recently, studies predominantly used hip-
worn monitors during waking hours only (e.g. 2, 3). The emergence of high-resolution raw 
acceleration wrist-worn accelerometers, which are acceptable for continuous wear (4), has 
facilitated measurement of sleep and sedentary time as well as physical activity across the entire 
24 hour cycle.  
 
Highly sophisticated technology and data-analysis techniques become irrelevant if the wearable 
monitor does not provide valid measures of physical behaviours or is not worn (5). Both wrist-
worn and hip-worn accelerometers can provide valid measures of physical activity, sedentary 
behavior (6, 7) and sleep (8, 9). However, with hip-worn monitors compliance is often low 
resulting in missing data (10, 11), which can lead to measurement error and to selection bias due 
to exclusion of participants with insufficient data (12). Poor compliance could be related to the 
wear-site, the look and comfort of the device, and/or the necessity for frequent removal of the 
monitor, e.g. for sleeping, water-based activities, or changing clothing, and therefore the 
requirement to remember to replace the monitor (5). Greater compliance has been attained with 
wrist-worn accelerometers; e.g. in the U.S. National Health and Nutrition Examination Survey 
(NHANES) 2003-2006, 40-70% of participants wore a hip-worn ActiGraph for 10 h/day (hours per 
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day) of wear for 6+ days, whereas when NHANES 2011-2014 switched to a wrist-worn ActiGraph 
70-80% of participants wore the monitors for 21-22 h/day for 6+ days (13).  Similarly, in UK 
Biobank >80% of over 100 000 participants wore the wrist-worn Axivity for at least 150 hours, 
equivalent to more than six 24 hour days (14).  
It is possible that the requirement for 24/7 wear as opposed to a waking wear only protocol 
contributes to high compliance, as well as the wear-site. The International Study of Childhood 
Obesity Lifestyle and the Environment (ISCOLE) used a 24 h wear protocol with the hip-worn 
ActiGraph and consistently captured more than 22 h of wear time over a 24 h day in children, aged 
9-11 years, across all 12 ISCOLE countries (15). However, when children (4) or adolescents (11) 
were requested to wear wrist and hip-worn monitors concurrently, compliance to a wrist-worn 
monitor was greater than for a hip-worn monitor for both waking day (4) and 24 h per day 
protocols (11). 
Evidence for factors that are associated with compliance largely come from cross-sectional studies 
with hip-worn monitors and are inconclusive. For example, studies have reported that: overweight 
and obese children are both less compliant (16) and more compliant (17); age is not associated 
with compliance (17) and lower in older than younger children (18, 19, 20); monitor wear-time is 
higher in South Asians and black African-Caribbean children than White Europeans (21) and non-
white children are less likely to return reliable accelerometer data than white children (16). The 
definition used for non-wear time appears to impact on apparent associations with compliance. 
This may be due to some groups, e.g. older and overweight/obese children, accumulating longer 
prolonged bouts of sedentary time that are more likely to be misclassified as non-wear, depending 
on the non-wear definition applied (12).  Compliance is also reported to be worse in children who 
self-report doing less leisure time physical activity (16) or exercise (16), and in economically 
disadvantaged groups (16, 22). 
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A consistent finding is that compliance to hip-worn accelerometers tends to drop off with a 
requirement for repeated deployments (e.g. in longitudinal studies) (10, 20, 23, 24). Achieving 
high compliance over repeated deployments is crucial when evaluating interventions or for any 
study evaluating changes in patterns of physical activity and/or their associations with health 
outcomes. Notably, following concurrent 24/7 wear of wrist and hip monitors, adolescents have 
reported that they would be more willing to wear a monitor on the wrist than the hip on a further 
occasion (11). A recent study showed children’s cumulative compliance to 24 h wear of wrist-worn 
accelerometers at two time-points was high at over 80% (25). To our knowledge there are no 
studies that have assessed compliance to 24 h wear of wrist-worn accelerometers over more than 
two deployments, or the factors associated with cumulative compliance to 24 h wear of wrist-
worn accelerometers. It is important to determine the degree to which compliance drops off over 
repeated deployments and which factors, modifiable or not, are associated with compliance, to 
aid with study planning.  
Recently, we used wrist-worn accelerometers to evaluate the effectiveness of the ‘Girls Active’ 
school-based physical activity programme for changing behaviours, primarily moderate-to-
vigorous physical activity (MVPA) (26). The protocol requested girls, aged 11-14 y at baseline, to 
wear a sports watch style wrist-worn accelerometer 24 h/ day for seven days at three deployment 
points: baseline, 7-months and 14-months.  
 
 The main aim of this analysis was to determine the cross-sectional and cumulative compliance to 
accelerometer wear at three deployment points in adolescent girls participating in the evaluation 
of Girls Active (26). We also aimed to determine: a) the number of days of accelerometer wear 
required to obtain a measure of physical activity that could be considered equivalent to a 7-day 
measure; and b) whether group allocation (intervention/control), SES (socio-economic status), 
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ethnicity, BMI (body mass index) z-score, biological maturity status, physical activity level, day of 
accelerometer deployment or prior compliance were associated with compliance. 
 
Methods 
 
Data for this study were obtained from the evaluation of the Youth Sports Trust’s Girls Active 
school-based physical activity programme (26). The evaluation included 20 schools in and on the 
boundary of Leicestershire and Rutland, with 10 schools randomised to receive the Girls Active 
intervention and 10 schools randomised to continue with usual practice. Approximately 90 girls, 
aged 11-14 y, were invited to participate from each school. They were provided with an 
information pack containing a letter of invitation, separate participant and parent/guardian 
information sheets, and an opt out consent form which they were given two weeks to return. Data 
were collected at baseline, 7-months and 14-months. Ethical approval for the evaluation was 
obtained from the University of Leicester’s College of Medicine and Biological Sciences Research 
Ethics representative. This paper focuses on monitor compliance only; the Girls Active evaluation is 
described in detail elsewhere (26).  
In brief, data were collected in measurement sessions run during the school day at baseline, 7-
months and 14-months. Following the baseline measurement session, schools were randomised to 
the intervention or the control condition stratified by school size (pupil median: <850, ≥850) and 
percentage of black and minority ethnicity (BME) pupils (median: <20%, ≥20%). Following each 
measurement session girls were requested to wear a GENEActiv accelerometer (ActivInsights Ltd., 
Cambridgeshire, UK) on their non-dominant wrist for 24 hours/day for 7-days and told they would 
be given a £5 voucher if they wore the device for enough time during the week (duration not 
specified). 
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Height, sitting height and mass were measured at each measurement session using standardised 
procedures. Body mass index was calculated and expressed in z-scores according to reference 
curves for the UK (27). Age (in months) was calculated from date of birth to date of measurement, 
ethnicity was self-reported and later collapsed into categories of White European (WE), South 
Asian (SA) or other, and socioeconomic status (SES) was estimated using the index of multiple 
deprivation (IMD) from self-reported postcode. The number of years a girl was from her age at 
peak height velocity (APHV), an indicator of biological maturity, was predicted from baseline 
measures of height, sitting height, leg length and age. Girls with an APHV within one standard 
deviation of the mean were classed as ‘average maturing’ or ‘on time’; those with an APHV greater 
than one standard deviation below the mean as ‘early maturers’; and those with an APHV greater 
than one standard deviation above the mean as ‘late maturers’ (28). 
 
Accelerometer processing 
 
The GENEActivs were initialised to collect data at 100 Hz and uploaded using GENEActiv PC 
software version 2.9. The GENEActiv .bin files were analysed with R-package GGIR version 1.2-2 
(http://cran.r-project.org) (29, 30). Signal processing in GGIR includes autocalibration using local 
gravity as a reference (30); detection of sustained abnormally high values; detection of non-wear; 
and calculation of the average magnitude of dynamic acceleration corrected for gravity (Euclidean 
Norm minus 1 g, ENMO) averaged over 5 s epochs and expressed in milli-gravitational units (mg). 
 
Files were excluded from all analyses if post-calibration error was greater than 0.02 g (31) and 
individual days were classified as invalid and excluded if wear-time was less than 16 h (32). 
Detection of non-wear has been described in detail previously (See ‘Procedure for non-wear 
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detection’ in supplementary document to van Hees et al. (29)). Briefly, non-wear is estimated 
based on the standard deviation and value range of each axis, calculated for 60 min windows with 
15-min sliding window. The window is classified as non-wear if, for at least 2 out of the 3 axes the 
SD (standard deviation) is less than 13 mg or the value range is less than 50 mg. 
 
Physical Activity was expressed as average acceleration (mg) and time accumulated in moderate-
to-vigorous physical activity per day (MVPA), defined as time accumulated above an acceleration 
of 200 mg (33). 
 
Analyses 
 
Descriptive statistics were calculated for relevant demographic and physical variables using mean 
(standard deviation) for continuous variables and percentage for categorical variables. Ethnicity, 
SES, APHV and maturity status were calculated from baseline data. All other variables were 
calculated at each time-point.  
 
Compliance 
 
Compliance was calculated for a minimum of 1-, 2-, 3-, 4-, 5-, 6-, and 7-valid days, and also for a 
minimum of 4-valid days where at least one day was a weekend day as has been recommended 
(34). Cross-sectional compliance was calculated as the number of girls achieving a given minimum 
number of valid days (>16 h) at each time-point (32). Cumulative compliance was calculated as the 
number of girls achieving a given minimum number of valid days at repeated deployment points: 
baseline and 7-months; baseline and 14-months; baseline, 7- and 14-months. Data loss due to zero 
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valid days or technical problems (file length <2 days, failed calibration) was also calculated cross-
sectionally for each time-point and longitudinally for each set of deployment points. 
 
Days of measurement required 
 
We used pairwise 95% equivalence tests to determine the number of days of measurement 
required to obtain physical activity outcomes that could be considered equivalent to a 7-day 
measure. If the 95% CI (confidence interval) for the mean physical activity assessed from n days 
fell within a ±5% equivalence zone of the 7-day measure (35) the measure was deemed 
equivalent. This analysis was carried out for 1-, 2-, 3-, 4-, 5- and 6 days at each of the three 
deployment points for average acceleration and for MVPA and, by definition, included only 
participants with 7-valid days.   
 
Associations with compliance 
 
Potential predictors of compliance considered were: age (continuous in years), SES (continuous), 
BMI z-score (continuous), physical activity level (continuous in mg), randomisation 
(control/intervention), maturity status (early maturers, average maturers, late maturers) ethnicity 
(WE, SA, other), first 24 h day of accelerometer measurement (Fri/Sat/Mon/Tues/Wed/Thurs; the 
first full day of measurement was never a Sunday) and prior compliance (continuous, number of 
valid days at baseline and/or 7-months). When considering predictors of compliance, all 
accelerometer files that were less than 6-days in duration were removed. This was to ensure that 
all included participants had the potential for maximum compliance, i.e. there was no fault of the 
monitor or artificially short measurement period (Baseline N = 34, 7-months N = 38, 14-months N = 
25). These files were not removed from the estimates of cross-sectional and longitudinal 
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compliance to ensure that these estimates reflected a ‘real world’ compliance result from 
accelerometer deployment. Generalised estimating equations (GEE) were used to determine 
predictors of compliance controlling for clustering at the school level (Model 1) and, in addition, 
controlling for all other predictors except prior compliance (Model 2). Finally, Model 3 extended 
Model 2 to assess the impact of prior compliance on compliance at 7-months and 14-months. 
Continuous variables were centred prior to entry into the GEE. 
 
Results 
 
At baseline, 7-months and 14-months 1734, 1381 and 1326 girls, respectively, were requested to 
wear the GENEActiv. The decreasing sample size reflects dropout/loss to follow up from the 
evaluation. From the variables calculated at baseline (data not in Table), the sample was 
predominantly WE (76.7%), with 11.6% SA and 11.6% other ethnicity. Approximately two thirds of 
the sample were normal weight, 20% overweight, 10% obese and 4% underweight at each time-
point. Based on APHV, approximately 15% of the sample were classified as early maturing, 15% as 
late maturing and 70% of the sample ‘on time’. A summary of the other descriptive characteristics 
at baseline and follow-up is shown in Table 1. 
 
Cross-sectional compliance 
 
Figure 1a shows the percentage of girls by the number of valid days wear at each of the three 
deployment points. The total height of each column represents the total participating at that time-
point (100%) and the height of the black column represents the percentage of girls with the 
specified number of minimum days.  Exact percentages are shown in Supplementary Digital 
Content (SDC) 1. Cross-sectionally, around 80% of girls provided 7-days of valid wear at baseline 
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and at 7-months; this dropped to just under 70% of girls providing 7-days of valid wear at 14-
months. Almost all girls (>96%) provided at least one valid day of wear, irrespective of time-point.  
 
Over 90% of the baseline, 7-month and 14-month samples provided a minimum of 6-, 4- and 3-
valid days of data, respectively. At baseline, 7-months and 14-months 94%, 90% and 84%, 
respectively, provided at least 3-valid weekdays and 1-valid weekend day (SDC1). The mean (SD) 
number of hours of wear per valid day was consistent across deployment points at ~23.5 ± ~1.5 h 
(Table 1). 
 
Data loss due to zero valid days or technical problems was very low at 0.6% and 0.9%, respectively, 
at baseline, 1.1% and 1.2%, respectively, at 7-months and 1.7% and 2.2%, respectively, at 14-
months. Two girls (0.2%) declined to wear the monitor at 14-months, but there was no refusal to 
wear at baseline or 7-months.  
 
Cumulative compliance 
 
Figure 1b shows the percentage of girls by the number of valid days wear for repeated 
deployment points: baseline and 7-months (n = 1381); baseline and 14-months (n = 1326); 
baseline, 7-months and 14-months (n = 1227). Again, the total height of each column represents 
the total participating at that set of deployment points (100%) and the height of the black column 
represents the percentage of girls with the specified number of minimum days. The left set of 
columns show the percentage of girls who had a minimum of one day’s wear at both baseline and 
7-months through to those who had 7-days wear at both baseline and 7-months. The middle set of 
columns show the percentage of girls who had a minimum of 1-day’s wear at both baseline and 
14-months through to those who had 7-days wear at both baseline and 14-months. The right set 
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of columns show the percentage of girls who had a minimum of 1-day’s wear at all three 
deployment points through to those who had 7-days wear at all three deployment points. Exact 
percentages are shown in SDC 1. 
 
All percentages are expressed as a percentage of girls participating in the evaluation at all of the 
deployment points concerned. Note, the cumulative sample size for all three deployment points 
was lower than for baseline and 14-months due to missing data at 7-months, e.g. one complete 
school dropped out at 7-months, but returned at 14-months. 
 
68%, 59% and 52% of girls provided a minimum of 7-valid days for baseline and 7-month 
deployment points, baseline and 14-month deployment points, and all three deployment points, 
respectively. This increased to 81%, 74% and 67%, respectively, when considering a minimum of 6-
valid days. Applying wear criteria of 3-valid weekdays and 1-valid weekend day lead to inclusion of 
87%, 81% and 76% of girls for both baseline and 7-months, both baseline and 14-months, and all 
three deployment points, respectively (SDC1). The vast majority of girls (91%) provided at least 
one valid day of wear for all three deployment points.  
 
Data loss due to zero valid days or technical problems across sets of deployment points was 2.9% 
and 2.3%, respectively, for baseline and seven months, 3.2% and 2.6%, respectively, for baseline 
and 14-months and 5.0% and 4.0% for all three deployment points. 
 
Days of measurement required 
 
Irrespective of time-point, physical activity was over-estimated, relative to the 7-day measure, if 
only 1- or 2- days of measurement were used (Figure 2: average acceleration; Figure 3: MVPA) . 
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Estimates of physical activity level from 3- to 6- days of measurement could be considered 
equivalent to the 7-day measure (i.e. the 95% CI for the mean of the 3-, 4-, 5- and 6- day measure 
fell within ±5% of the mean of the 7-day measure). The magnitude of these differences between 
the means was <0.6 mg for average acceleration, and <1 min for MVPA.  
 
Associations with compliance  
 
The number of valid days by deployment point, intervention/control group and categorical 
variables is shown in SDC2. Irrespective of categorical variable the mean number of valid days was 
>6, with the exception of the control group at 14-months (mean (SD) = 5.9 (1.9) valid days).  
 
SDC3 shows the regression models predicting compliance, defined as the total number of hours 
the monitor was worn across the week, adjusted for clustering at the school level only.  Table 2 
shows the regression models further adjusted for all common predictors and results in Table 3 
further adjust the models predicting hours of monitor wear at 7-months and 14-months for prior 
compliance (number of valid days of wear at prior deployment points).  
 
Age was negatively associated with hours of monitor wear in the unadjusted model (SDC3). When 
controlling for all common predictors (Table 2), physical activity level was consistently and 
positively associated with hours of monitor wear with the association tending to get stronger as 
the study progressed. An increase of 1 mg in average acceleration was associated with an 
additional 0.2, 0.3 and 0.4 h monitor wear at successive deployment points, respectively. The SD 
and size of the 95% CI for average acceleration is approximately 8 and 30 mg, respectively. 
Therefore, the difference in compliance associated with activity levels at the lower and upper 
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limits of the CI would be approximately 6 h (baseline) to 12 h (14 months), or up to half a day of 
monitor wear over the week. 
 
At baseline and 14-months, but not 7-months, being in the intervention group was associated with 
4 h (baseline) to 7 h (14 months) more monitor wear. The hours of monitor wear were higher (2-4 
h) in SA than WE, increasing from 2 h longer at baseline to 4 h longer at 14-months. Starting the 
first full day of accelerometer wear on a Friday (i.e. deployment on Thursday) led to the highest 
hours of monitor wear, approximately 6 h longer than a Saturday (i.e. deployment on Friday) and 3 
h longer than mid-week at baseline, 6 h longer than a Monday at 7-months and 3 h longer than a 
Wednesday at 14-months. 
 
Prior compliance predicted hours of monitor wear (Table 3), with the strongest effects for the 
deployment immediately preceding the one of interest. For example, every valid day of wear at 
baseline was associated with an extra 11.4 h wear at 7-months and 6.6 h extra wear at 14-months, 
and every valid day of wear at 7-months was associated with an extra 9.7 h of wear at 14-months.  
 
After controlling for prior compliance, associations of hours of monitor wear with physical activity 
level, ethnic group and accelerometer measurement start day were largely similar to the model 
adjusting for all common predictors (Table 2).  
 
Discussion 
 
Compliance to wearing a sports watch style wrist-worn accelerometer during wake and sleep was 
high, with six valid days of wear being obtained from over 90% of girls at baseline. This reduced 
with repeated wear occasions, but remained high with 78% of girls providing six valid days of wear 
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on the third deployment, over a year later. Importantly, a minimum of three days of wear 
provided measures of overall physical activity and MVPA that were equivalent to 7-day measures. 
Cross-sectionally, this was obtained from >95% of girls at baseline and at 7-months and from 91% 
of girls at 14-months. Cumulatively 84% of girls across all three deployment points provided three 
valid days of wear across all three deployment points, consistent with the compliance reported in 
children across two deployment points (25). Examining just under 30 000 adult participant with 
perfect 7-day wear time compliance from the UK Biobank cohort, Doherty et al. (14) also reported 
that 72 h (three days) of accelerometer wear were needed for a reliable measure, defined as 
within 10% of a complete 7-day measure (determined using intra-class correlation coefficients).  
 
Employing a waking wear protocol, Howie et al. (36) observed a drop in 10-12 y old children’s 
compliance to a wrist-worn accelerometer from 89% at baseline to 83%, 82% and 79% at the end 
of three subsequent 8-week conditions (n = 73), when compliance was defined as >10 h wear per 
day on three weekdays and one weekend day. The decrease in compliance from waking wear 
protocols appears to come from shorter daily wear durations on the repeated occasions, as 
compliance was relatively unchanged over the four deployments (96% to 92%) when a less 
stringent compliance definition of eight hours wear per day on three days was used. Similarly, in a 
cross-sectional study employing a waking wear protocol, >95% of 9-10 y old children (n = 129) 
achieved one valid day of wrist accelerometer wear during a single deployment, whether a valid 
day was defined as 6 or 12 hours (4). However, this diverged considerably when more valid days 
were required, with less than half the children who met the 6 h wear per day criteria on six days 
providing 12 h wear per day for six days (64% and 30%, respectively) (4). During a 24 h/day wear 
protocol, if a monitor is worn on a given day, the daily hours of wear tend to far exceed minimum 
wear definitions (13, 14, 15, 25). For example, in the current study the average daily hours of wear 
were >23 h on valid days irrespective of time-point, with around 75% of valid days at each time-
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point containing 24 h of wear. Consistent with this, using a 24 h/day wrist accelerometer protocol 
Price et al. (25) showed that the percentage of 9-10 y old children (N=851) complying to minimum 
wear criteria of 8 and 16 h over 1-6 days differed by less than 1.8 percentage points.  This suggests 
that classification of valid days in 24 h protocols is less dependent on variations in minimal wear 
duration, with invalid days resulting mainly from removal of the monitor for the majority of a day 
and/or participants stopping wear before the measurement period has finished.  
 
Irrespective of deployment point, higher compliance was associated with being more active, being 
SA, and the first day of full monitor wear not being on a weekend or a Monday. Each of these was 
associated with up to half a day of extra wear. At 14-months, being in the intervention group was 
also associated with half a day of extra wear. At baseline, in the model adjusted for clustering at 
the school level and all other predictors, being in the intervention group was associated with 4 h 
of extra wear. However, this was not the case in the model adjusted for clustering only and it 
should be noted that, at the baseline measure, the participants were unaware of which group 
their school had been randomised to.  Considering all deployment points, there was a tendency 
for Friday to be the optimal first full measurement day (i.e. accelerometer deployment on 
Thursday). Saturday was the worst first full measurement day at baseline, i.e. accelerometer 
deployment on Friday (note 7-month and 14-month deployment points did not use a Saturday as a 
first full measurement day); this suggests that it may be beneficial if the first and last full days of 
accelerometer wear are in school, where other children may also be wearing an accelerometer 
and/or teachers are aware of the study. Overall, prior compliance was the strongest predictor of 
subsequent compliance, with every extra valid day at a given time-point being associated with an 
extra 10-12 h of compliance for the next deployment point. Studies with multiple deployment 
points may benefit from identifying participants with poor compliance at the first deployment 
point and trying to establish any reasons for poor compliance. This may facilitate the 
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implementation of targeted strategies aimed at improving the compliance of these participants at 
the next deployment point.  
 
Evidence in the literature for factors associated with compliance is mixed (16). Further, studies 
have focussed on compliance to wearing accelerometers at the hip for a waking protocol (e.g. 12, 
16). As compliance to protocols incorporating wrist-wear and 24/7 wear differs (11, 13, 15), the 
factors associated with compliance also likely differ. Further, many studies took place before the 
recent explosion in consumer wearables (37) which have likely ‘normalised’ the wearing of activity 
monitors. This limits the extent to which our findings are comparable with those in the literature. 
 
The size of associations with compliance were larger at 14-months than baseline. It is conceivable 
this was related to the increasing age of the girls, especially as age was negatively associated with 
compliance at each time-point in the unadjusted model and compliance has been shown to be 
lower in older children previously (18, 19, 20). However, as the effect of age largely disappeared 
after controlling for other associates this was more likely an effect of the repeated deployment 
rather than age. 
 
Although factors associated with compliance were identified, it is notable that overall compliance 
was generally high. The use of a 24/7 protocol with wrist-worn accelerometers may reduce the 
impact of demographics and other variables on the quality of the physical activity data obtained. 
This is supported by the consistently high compliance reported to 24/7 wrist accelerometer wear 
in a range of different populations and different monitor deployment methods. For example, in a 
face-to-face physical activity intervention targeting rural adult Australians in South Australia (n= 
171), 6+ valid days of GENEActiv wear were provided by 93% of participants at baseline (38), 
similar to baseline compliance in the current study with adolescent girls. In UK Biobank 
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accelerometers were mailed out and 80.6% of >100 000 participants, aged 40-69 y, wore the 
wrist-worn Axivity 24/7 for 150 h (6.25 days) (14), only approximately 10% lower than the studies 
using a face-to-face protocol. The percentage providing three days of data was >93%, very similar 
to the current study. Irrespective, poor compliance did lead to some data loss. When designing 
studies and calculating sample size, researchers should take into account data loss associated with 
compliance to the accelerometer protocol they are deploying as well as considering dropout from 
the study. 
 
This study has a number of limitations that should be highlighted. We do not know the degree to 
which the small financial incentive may have contributed to compliance in this study. This is a 
limitation, as it has previously been reported that incentives for returning accelerometers and for 
providing sufficient data leads to greater compliance to waking protocols with hip-worn 
accelerometers in adolescents (39, 40). Secondly, as stated in the introduction, the definition used 
for non-wear time impacts on estimates of compliance and on apparent associations with 
compliance. Therefore, it may be necessary to replicate this type of study as methods for wear-
time detection advance. Thirdly, these findings are specific to our population of adolescent girls 
and may not be generalizable to other age-groups, boys and/or different monitor deployment 
protocols. Finally, we did not consider whether compliance was affected by weather conditions; 
future studies should investigate whether variation in season, e.g. weather, seasonal attire and 
seasonal sports, impacts on compliance. 
 
In conclusion, the high cross-sectional and cumulative compliance to 24/7 wrist accelerometer 
wear in the evaluation is very encouraging, particularly as adolescent girls can be a challenging 
population to assess with accelerometry. They have expressed more concerns about the 
appearance of (hip-worn) accelerometers than boys (40), although have also indicated that they 
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found the sports watch style GENEActiv wrist-worn monitor less embarrassing (11). Three-
quarters of the sample provided six valid days at baseline and 14-months, or five valid days at all 
three deployment points. A valid estimate of physical activity (equivalent to a 7-day measure) was 
obtained with three days; achieved by >90% of the sample for any single time-point, and >84% of 
girls for multiple deployment points. High compliance reduces measurement error as a more 
reliable and complete measure of physical behaviours can be captured and reduces bias as fewer 
participants are excluded due to failing to meet minimum wear criteria.  
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Table 1. Descriptive characteristics of the Girls Active participants included in these analyses  
 Mean (SD) value at each deployment point 
except where stated otherwise 
Variable Baseline  
(n=1734) 
7-months  
(n = 1381) 
14-months 
(n=1326)  
Age (y) 12.8 (0.8) 13.5 (0.8) 14.0 (0.8) 
Years from Age at Peak Height Velocity (APHV) 0.7 (0.8) 1.4 (0.8) 1.8 (0.8) 
Height (cm) 155.9 (7.9) 158.9 (7.2) 160.2 (6.9) 
Mass (kg) 48.8 (12.4) 52.1 (12.5) 54.1 (12.5) 
Body mass index (kg·m-2) 19.9 (4.0) 20.5 (4.1) 21.0 (4.2) 
Body mass index z-score 0.18 (1.33) 0.25 (1.32) 0.33 (1.27) 
Average daily acceleration (mg) 36.2 (8.9) 33.9 (7.8) 34.5 (8.5) 
MVPA (min/day) 45.5 (20.8) 41.0 (18.4) 42.7 (20.3) 
Compliance: Valid days* 6.7 (1.1) 6.4 (1.4) 6.1 (1.7) 
Compliance: Hours per valid day* 
Median (25th to 75th %ile) 
23.6 (1.2) 
24.0 (24.0, 24.0) 
23.5 (1.5) 
24.0 (23.8, 24.0) 
23.3 (1.7) 
23.0 (24.0, 24.0) 
Compliance: Hours of monitor wear†  161.4 (17.3) 157.9 (21.9) 153.0 (26.7) 
Compliance: Hours per day 22.9 (3.7) 22.1 (5.0) 21.4 (5.7) 
* Valid day: 16 h minimum wear 
† Maximum hours = 167.3 h (7 days: GENEActiv max recording time at 100 Hz) 
SD = standard deviation; MVPA = moderate-to-vigorous physical activity 
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Table 2. Generalised estimating equation for prediction of total number of hours monitor worn at baseline, 7-months and 14-months, adjusted for clustering 
at school level and all other predictors except prior compliance (Model 2).  
 
 Baseline (listwise N= 1529) 
 
7 months (listwise N = 1214) 
 
14 months (listwise N = 1157) 
 
Continuous variables 
 
Change in 
compliance 
(h) 
95% CI Change in 
compliance (h) 
95% CI Change in 
compliance (h) 
95% CI 
Age -0.23 -1.37, 0.91 -1.38 -2.50, -0.25 -1.18 -3.02, 0.66 
Socio-economic status (SES) 0.00 -0.00, 0.00 0.00 -0.00, 0.00 0.00 -0.00,0.00 
BMI z-score -0.05 -0.59, 0.49 0.56 -0.43, 1.56 0.59 -0.67, 1.84 
Physical activity level  
(average acceleration, mg) 
0.21 0.06, 0.36 0.32 0.17, 0.46 0.37 0.16, 0.58 
        
Categorical  variables 
 
      
Randomisation Control 0 Reference 0 Reference 0 Reference 
 Intervention 
  
3.94 1.68, 6.20 1.63 -0.81, 4.07 7.22 4.17, 10.26 
Biological maturity Early maturers 0 Reference 0 Reference 0 Reference 
Average maturers -0.81 -2.76, 1.14 -1.00 -4.93, 2.92 -2.06 -5.65, 1.53 
Late maturers 
 
-1.17 -4.32, 1.98 -0.15 -4.72, 4.41 0.02 -4.27, 4.31 
Ethnicity White European 0 Reference 0 Reference 0 Reference 
South Asian  1.91 0.57, 3.25 3.50 0.70, 6.30 4.01 0.72, 7.31 
Other  
 
1.61 -0.31, 3.54 0.54 -2.40, 3.49 -2.07 -7.68, 3.55 
Start day Friday 0 Reference 0 Reference 0 Reference 
 Saturday -5.92 -10.89, 0.96 N/A N/A N/A N/A 
Monday N/A N/A -5.81 -7.13, -4.48 N/A N/A 
Tuesday -2.94 -5.25, -0.63 -0.82 -5.59, 3.95 -3.65 -8.10, 0.80 
Wednesday -3.68 -6.37, -0.99 -2.75 -5.72, 0.22 -2.64 -4.65, -0.64 
Thursday -1.30 -3.86, 1.27 -1.53 -4.04, 0.97 -2.28 -6.39, 1.83 
 
Significant results denoted in bold (p <0.05) 
N.B. Excluded participants whose monitors recorded for <6 days to ensure no faulty devices and/or short measurement periods (Baseline N = 34, 7-months N = 38, 14-months N = 
25) 
 
h = hours; CI = confidence interval  
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Table 3. Generalised estimating equation for prediction of total number of hours monitor worn at 7-months and 14-months, adjusted for clustering at school 
level and all other predictors including prior compliance (Model 3). 
 
 7 months (listwise N= 1169) 
Compliance at baseline 
14 months (listwise N = 1113) 
Compliance at baseline 
14 months (listwise N = 974) 
Compliance at baseline and 7 months 
Continuous variables 
 
Change in 
compliance (h) 
95% CI Change in 
compliance (h) 
95% CI Change in 
compliance (h) 
95% CI 
Age -1.67 -2.77, -0.58 -0.74 -2.61, 1.13 -0.40 -2.19, 1.39 
Socio-economic status (SES) -0.00 -0.00, 0.00 0.00 -0.00, 0.00 0.00 -0.00, 0.00 
BMI z-score 0.20 -0.84,  1.24 0.53 -0.62, 1.68 0.14 -0.92, 1.19 
Physical activity level (average acceleration, mg) 0.27 0.11, 0.43 0.38 0.14, 0.63 0.28 0.02, 0.55 
Baseline compliance (days) 11.38 6.65, 16.11 6.54 0.30, 12.78 2.91 -2.03, 7.86 
7-month compliance (days) N/A N/A N/A N/A 9.74 6.38, 13.11 
        
Categorical  variables 
 
      
Randomisation Control 0 Reference 0 Reference 0 Reference 
 Intervention  
 
1.14 -1.11, 3.39 6.60 3.01, 10.18 5.42 3.79, 7.06 
Biological maturity Early maturers 0 Reference 0 Reference 0 Reference 
Average maturers -0.62 -4.63, 3.38 -2.74 -6.28, 0.79 -1.16 -4.12, 1.81 
Late maturers 
 
0.13 -4.91, 5.16 -0.86 -4.92, 3.19 -0.66 -4.34, 3.01 
Ethnicity White European 0 Reference 0 Reference 0 Reference 
South Asian  3.29 0.75, 5.82 4.87 0.75, 9.00 5.66 2.01, 9.30 
Other  
 
-0.63 -3.42, 2.17 -2.32 -7.68, 3.04 -1.36 -6.57, 3.85 
Start day Friday 0 Reference 0 Reference 0 Reference 
Saturday N/A N/A N/A N/A N/A N/A 
Monday -7.40 -8.70, -6.10 N/A N/A N/A N/A 
Tuesday 1.87 -0.39, 4.12 -3.58 -8.84, 1.67 -1.37 -4.15, 1.41 
Wednesday -2.39 -4.81, 0.04 -2.35 -4.40, -0.30 -1.67 -4.33, 1.00 
Thursday -0.58 -2.89, 1.73 -2.45 -6.75, 1.86 -3.58 -6.23, -0.93 
 
Significant results denoted in bold (p <0.05) 
N.B. Excluded participants whose monitors recorded for <6 days to ensure no faulty devices and/or short measurement periods (Baseline N = 34, 7-months N = 38, 14-months N = 
25) 
 
h = hours; CI = confidence interval 
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SUPPLEMENTARY DIGITAL CONTENT 1. Percentage of girls meeting minimum wear criteria at each deployment point (cross-sectional) and at sets of 
deployments (cumulative).  
 
Cross-sectional: % of girls achieving minimum number of days at each deployment point 
Deployment point  
(months) 
1-day 2-days 3-days 4-days 5-days 6-days 7-days 4-days  
including weekend day 
0 (n=1734) 98.5 97.8 96.4 95.2 94.1 92.0 83.3 94.5 
7 (n=1381) 97.7 96.6 94.6 92.5 89.4 85.5 77.4 90.3 
14 (n=1326) 95.9 93.7 90.9 87.3 84.1 78.4 67.7 84.0 
Cumulative: % of girls achieving minimum number of days at each set of deployment points 
0, 7 (n=1381) 95.7 94.4 91.5 89.0 85.7 80.7 67.5 86.8 
0, 14 (n=1326) 94.0 91.5 88.1 84.0 80.5 73.8 59.4 80.7 
0, 7, 14 (n=1227) 90.9 88.1 84.0 79.1 74.6 67.4 51.6 75.7 
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SUPPLEMENTARY DIGITAL CONTENT 2. Number of valid days (mean(SD)) at each deployment point by demographic and physical categories.  
 
  Deployment point 
Variable  Baseline 7 months 14 months 
Categorical variables  
  N(%) Valid days 
(mean(SD)) 
N(%) Valid days 
(mean(SD)) 
N(%) 
 
Valid days 
(mean(SD)) 
Experimental 
group 
Control 843(50.2) 6.6 (1.1) 590(44.5) 6.5 (1.4) 583(46.0) 5.9 (1.9) 
Intervention 
 
836(49.8) 6.8 (0.8) 735(55.5) 6.5 (1.3) 684(54.0) 6.4 (1.3) 
Biological 
maturity 
Early 265(15.9) 6.8 (0.7) 202(15.3) 6.6 (1.1) 202(16.0) 6.2 (1.7) 
On time 1142(68.3) 6.7 (1.0) 906(68.6) 6.5 (1.4) 870(68.7) 6.2 (1.6) 
Late 
 
264(15.8) 6.7 (1.0) 212(16.1) 6.5 (1.2) 19(15.3) 6.2 (1.6) 
Weight 
status 
Normal weight 1182(71.7) 6.7 (0.9) 910(70.0) 6.5 (1.4) 871(69.9) 6.2 (1.7) 
Overweight 322(19.5) 6.7 (0.9) 269(20.7) 6.6 (1.1) 259(20.8) 6.2 (1.6) 
Obese 
 
144(8.7) 6.7 (0.9) 122(9.4) 6.6 (1.1) 116(9.3) 6.3 (1.4) 
Ethnicity White European 1291(77.1) 6.7 (0.9) 985(74.4) 6.5 (1.4) 937(74.1) 6.2 (1.6) 
South Asian 191(11.4) 6.7 (1.2) 164(12.4) 6.6 (1.3) 172(13.6) 6.3 (1.7) 
Other 
 
193(11.5) 6.8 (0.8) 175(13.2) 6.5 (1.2) 155(12.3) 6.0 (1.8) 
Start day Monday 0 N/A 76(5.7) 6.4 (1.3) 0 N/A 
Tuesday 336(20.0) 6.7 (1.0) 149(11.3) 6.5 (1.2) 302(23.8) 6.0 (1.8) 
Wednesday 330(19.7) 6.8 (0.8) 365(27.6) 6.4 (1.6) 290(22.9) 6.2 (1.6) 
Thursday 421(25.1) 6.8 (0.8) 289(21.8) 6.4 (1.4) 335(26.4) 6.2 (1.7) 
Friday 336(20.0) 6.8 (1.0) 446(33.7) 6.6 (1.1) 340(26.8) 6.3 (1.5) 
Saturday 256(15.3) 6.4 (1.1) 0 N/A 0 N/A 
 
N.B. Excluded participants whose monitors recorded for <6 days to ensure no faulty devices and/or short measurement periods (Baseline N = 34, 7-months N = 38, 14-months N = 
25) 
SD = standard deviation
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Figure 1. a) Cross-sectional compliance and data loss at baseline, 7-months and 14-months; b) Cumulative 
compliance and data loss at repeated time-points: Baseline and 7 months; Baseline and 14 months; 
Baseline, 7 months and 14 months 
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Figure 2. Equivalence between average acceleration measured for 7-days and for 1-6 days at a) baseline, b) 7-months and c) 14-months 
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Figure 3. Equivalence between MVPA measured for 7-days and for 1-6 days at a) baseline, b) 7-months and c) 14-months 
 
